1069 — China Health Technology Holding Cashflow Statement
0.000.00%
Last trade - 00:00- HK$46.32m
- HK$169.40m
- CNY90.22m
- 32
- 92
- 22
- 46
Annual cashflow statement for China Health Technology Holding, fiscal year end - June 30th, CNY millions except per share, conversion factor applied.
2021 June 30th | 2022 June 30th | 2023 June 30th | 2024 June 30th | 2025 June 30th | |
|---|---|---|---|---|---|
| Period Length: | 18 M | 12 M | 12 M | 12 M | 12 M |
| Source: | ARS | ARS | ARS | ARS | ARS |
| Standards: | HKAS | HKAS | HKAS | HKAS | HKAS |
| Status: | Final | Final | Final | Final | Final |
| Net Income/Starting Line | -554 | -20.4 | -10.8 | 200 | 23 |
| Depreciation | |||||
| Amortisation | |||||
| Non-Cash Items | 524 | 14.3 | 36 | -186 | 20.2 |
| Discontinued Operations | |||||
| Unusual Items | |||||
| Other Non-Cash Items | |||||
| Changes in Working Capital | 23.8 | 3.86 | -4.23 | 9.92 | -13.3 |
| Change in Accounts Receivable | |||||
| Change in Inventories | |||||
| Change in Other Assets | |||||
| Change in Accounts Payable | |||||
| Change in Payable / Accrued Expenses | |||||
| Other Operating Cash Flow | |||||
| Cash from Operating Activities | 0.159 | -0.466 | 23.4 | 28.9 | 34.7 |
| Capital Expenditures | 0 | — | -23.3 | -26.5 | -35.6 |
| Purchase of Fixed Assets | |||||
| Other Investing Cash Flow Items | -0.604 | 0.002 | 0.013 | 0.004 | 0.043 |
| Acquisition of Business | |||||
| Sale of Business | |||||
| Sale of Fixed Assets | |||||
| Other Investing Cash Flow | |||||
| Cash from Investing Activities | -0.604 | 0.002 | -23.3 | -26.5 | -35.5 |
| Financing Cash Flow Items | -0.489 | 0 | — | — | -0.269 |
| Other Financing Cash Flow | |||||
| Net Issuance / Retirement of Stock | |||||
| Net Issuance / Retirement of Debt | |||||
| Cash from Financing Activities | -0.877 | -0.249 | 3.04 | -3.47 | 2.12 |
| Foreign Exchange Effects | |||||
| Beginning Cash Balance | |||||
| Ending Cash Balance | |||||
| Net Change in Cash | -1.36 | -0.713 | 3.22 | -1.1 | 1.26 |